Conference Reports for NATAP

Back

Lipodystrophy Workshop   July 8-11, 2003, Paris     Treatments for lipoatrophy. Are there improvements? Are they noticeable? - Written by Donald P. Kotler, MD St. Luke's-Roosevelt Hospital Center (8/25/03)   Lipoatrophy and Mitochondrial Toxicity Issues at the 5th Lipodystrophy Conference - Cecilia Shikuma, MD, University of Hawaii and the ACTG (8/4/03)   Glucose metabolism/insulin resistance, lipids and cardiovascular: report from Paris, IAS & Lipodystrophy Conferences - Michael Dube, MD, University of Indiana and the ACTG (7/10/03)   Switch to Abacavir Improves Fat Loss; Experimental Uridine Study Improves Mitochondrial Toxicity in Vitro - (7/10/03)   Atazanavir: Evaluation of Body Changes and Lipids/Glucose After 48 weeks Treatment - (7/10/03)   Rosiglitazone For Lipoatrophy: mixed results - (7/9/03)   Lipodystrophy Workshop - (7/8/03)